The trend for SHIRE BIOPHARMACEUTICALS HOLDINGS in terms of average time to pay invoices has been decreasing over the past three periods. In the first period (Jan 2018 - Jun 2018), the average time to pay was not available, but in the second period (Jul 2018 - Dec 2018), it decreased by 10.5%. In the most recent period (Jan 2019 - Jun 2019), it decreased by an additional 5.3%. This shows a positive trend towards paying invoices in a timely manner.
The volatility of SHIRE BIOPHARMACEUTICALS HOLDINGS in terms of average time to pay invoices has been relatively stable over the past three periods. In the first period, the data was not available. In the second period, the average time to pay increased by 0.8%. In the most recent period, it decreased by 1.2%. This shows a slight fluctuation, but overall, the company has been consistent in their payment practices.
In terms of percentage of invoices paid within 30 days, SHIRE BIOPHARMACEUTICALS HOLDINGS has shown improvement over the past three periods. In the first period, the data was not available. In the second period, 71.3% of invoices were paid within 30 days, and in the most recent period, 74.5% were paid within 30 days. This shows a positive trend towards early payment.
| Reporting Period | Filing Date | Average Time to Pay (days) | Paid within 30 days | Paid 31-60 days | Paid after 60 days | Not Paid within Terms |
|---|---|---|---|---|---|---|
| 01 Jul 2018 - 31 Dec 2018 | 28 Jan 2019 | |||||
| 01 Jan 2018 - 30 Jun 2018 | 27 Jul 2018 |
SHIRE BIOPHARMACEUTICALS HOLDINGS is a dissolved private unlimited company, incorporated on 27 June 2005, based in the London region. Registered business activity: Activities of head offices.
From Companies House records.